
The drug also demonstrated efficacy in improving sleep quality and reducing sleep disruption.

The drug also demonstrated efficacy in improving sleep quality and reducing sleep disruption.

Melodie Young, MSN, ANP-c, shares pearls on why prioritizing skin checks during Psoriasis Action Month in August is critical.

Catch up on coverage from the third day of the 2023 SDPA Annual Summer Dermatology Conference.

Megan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.

Joslyn Kirby, MD, discusses the importance of awareness and recognition in hidradenitis suppurativa from a clinician and patient perspective.

A poster presented at the SDPA Annual Summer Dermatology Conference revealed the abrocitinib did not have a significant impact on adolescent immune responses to Tdap vaccination.

With bimekizumab, the conservative imputation method led to higher response rates, achieved endpoints, and blocked IL-17A and IL-17F.

Catch up on coverage from the second day of the 2023 SDPA Annual Summer Dermatology Conference.

Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.

Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.

In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.

John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"

Darrell Rigel, MD, discusses his SDPA Annual Summer Dermatology Conference, "Inflammatory Dermatoses: A Case-Based Review," particularly highlighting the relationship between skin cancer and the inflammatory disease realm.

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference analyzed the growing threat of antifungal resistance, particularly with the treatment of onychomycosis in mind.

Nicole Gunasekera, MD, MBA, presented a session on disorders of pigmentation at the 2023 SDPA Annual Summer Dermatology Conference.

Catch up on coverage from the first day of the 2023 SDPA Annual Summer Dermatology Conference.

Catch up on visual highlights and views from the first day of the SDPA Annual Summer Dermatology Conference in Boston, MA.

Mark Lebwohl, MD, discusses his SDPA Annual Summer Dermatology Conference session, "Inflammatory Dermatoses: A Case-Based Review."

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed improvements to hyperpigmentation in a cohort of Black patients with moderate-to-severe acne.

Omar Noor, MD, FAAD, discusses cultural competency in caring for patients with skin of color in dermatology.

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed statistically significant improvements among patients with psoriasis receiving brodalumab treatment.

Omar Noor, MD, FAAD, discusses his SDPA session, "Clinical Pearls for Pediatric and Adult Dermatology."

When sessions, late-breaking research, and more conclude, there is no shortage of things to do in historic Boston.

Click here to answer today's poll.

The conference aimed at providing dermatology physician assistants with the latest in the field begins tomorrow in Boston, Massachusetts.

Dermatology Times had the opportunity to speak with numerous leading KOLs in the industry, live and virtually, at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Click here to answer this week's poll.

If you weren’t able to attend Fall Clinical for PAs and NPs or want to review our latest coverage and interviews, our full recap has you covered.

A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.

Roger Ceilley, MD, reviewed his best tips for ensuring the best patient outcomes after surgical procedures at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.